Navigation Links
Isolagen Inc. Completes Injections of Isolagen Therapy(TM) in Phase II/III Acne Scar Study
Date:10/21/2008

EXTON, Pa., Oct. 21 /PRNewswire-FirstCall/ -- Isolagen(TM), Inc. (Amex: ILE) announced today that all injections have been completed in the Phase II/III Study IT-A-008 investigating Isolagen Therapy(TM) for the treatment of moderate to severe facial acne scars. Further, approximately half of all of the study participants have completed the final observation visit. Isolagen anticipates the acne study will conclude in the first quarter of 2009.

"The second half of 2008 has been very productive for Isolagen as we continue to deliver on our clinical milestones on time and with positive results," said Declan Daly, Chief Executive Officer of Isolagen. "We previously announced positive top-line results from our pivotal Phase III wrinkle study and positive results from our open label Phase II study of the full face. We are very excited that our acne program is progressing on time and we believe the dermatology community will be very interested in this data early next year because of the unmet need for a minimally invasive acne scar treatment. Our current priority is to gain additional funding and secure a strategic partner to help us deliver on the exciting clinical promise of the Isolagen therapy in all of these areas."

About the Isolagen Process(TM) and Isolagen Therapy(TM)

The Isolagen Process(TM) is an innovative cellular processing system which creates a natural, living cell therapy. By multiplying a patient's own collagen-producing cells or fibroblasts into tens of millions of new cells, a personalized treatment is created which is then returned to the patient's skin. This treatment, known as the Isolagen Therapy(TM), is designed to improve skin damage caused by the normal effects of aging, sun damage, acne and burns.

About Isolagen, Inc.

Isolagen(TM), Inc. (Amex:

SOURCE Isolagen, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Isolagen, Inc. Postpones Annual Meeting
2. Isolagen Initiates Phase III Clinical Program to Investigate Isolagen Therapy(TM) for the Treatment of Acne Scars
3. Isolagen Modifies Ongoing Clinical Program for Acne Scars
4. Isolagen Inc. to Present at the 26th Annual JPMorgan Healthcare Conference
5. Isolagen Inc. Promotes Declan Daly to Chief Executive Officer (CEO)
6. Isolagen, Inc. Receives Notification Letter from American Stock Exchange
7. Isolagen, Inc. Promotes Todd Greenspan to Chief Financial Officer (CFO)
8. Isolagen, Inc. Sells Switzerland Facility
9. Isolagen, Inc. Reports Receipt of Initiation of Delisting Proceedings Notice from Amex
10. Eligard(R) six-month formulation successfully completes European approval procedure
11. The ScottCare Corporation Completes Acquisition of Rozinn Electronics, a Leading Manufacturer of Cardiac Diagnostic Products

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)...Dec. 1 Air Products (NYS...sly announced sale of the assets of its polyuretha...ane® and Versathane® tradenames to COIM ...rethane chemicals producer COIM SpA. ,, Includ...ility in Paulsboro, N.J. Terms of the agreement ar...
(Date:12/1/2009)...PRNewswire/ -- Abrazo Media Relations-- The Center.../ www.pedsorthopaedics.com ) located in Mesa, Ariz...Dr. J. Hunt Udall to its practice. ,, Dr. Udal...rgery after recently completing his fellowship tra...ts where he focused on adult and pediatric orthopa...
(Date:12/1/2009)...es Foundation will honor The Forsyth Institute wit...rds celebration to be held on February 27, 2010, i...A Annual Session & Exhibition. The William J. Gies...cognize contributions to, and support of global or...e listing of Gies Award winners, visit www.adeagi...
(Date:12/1/2009)...ign versus cancerous lesions, researchers say , ... used with ultrasound, elastography helps distingu...hich reduces unnecessary biopsies, U.S. researcher...ons that are biopsied turn out to be benign, accor... a lot of room to improve specificity with ultraso...
(Date:12/1/2009)... 1 For many employers, the issue o...an just an employee benefit, it,s providing for th...Stores, Inc. is leading this effort, with the help...llness center at its corporate offices, bringing q...y to employees and their dependents. ,, Begi...
Breaking Medicine News(10 mins):Health News:Air Products Completes Sale of Polyurethane Pre-Polymers Business to COIM USA 2Health News:Orthopaedic Surgeon Dr. J. Hunt Udall Joins the Center for Pediatric Orthopaedics and Scoliosis as One of Few Trained Doctors to Perform Minimally Invasive Hip Arthroscopy 2Health News:The Forsyth Institute receives the William J. Gies Award for outstanding achievement 2Health News:Ultrasound With Elastography May Cut Down on Biopsies 2Health News:Hobby Lobby Selects Concentra to Open Health Center 2Health News:Hobby Lobby Selects Concentra to Open Health Center 3
... - The University of Pittsburgh Medical Cente...ber of the Leptos Group - announced today that the...h care center in Paphos, Cyprus, designed to offer... and Nicosia, Cyprus (PRWEB) February 27, 2009 -- ...
... National MS Awareness Week highlights moveme... trials are under way. , ...atients with multiple sclerosis is gaining tractio...MS Awareness Week on March 2-8, 2009. Organization...
...ell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC...ial meeting of shareholders from Friday, February ...llow additional time for the proxy materials, firs...ders receive at least 20 days written notice of th...
... the Global Prevention Network(TM) as Asian Affili...ventive Medicine(R), a leader in disease preventio...th Parkway Group Healthcare Pte Ltd, a leading hea... Under the agreement, ParkwayHealth will become th...
... Unique Bed Benefits, Plus New Series and Mod...ess Starts at $699.99; One of Three Queen Sets Now...is, MN (Vocus) February 26, 2009 -- In today,s unc...ognize an unbeatable value. In response to the eco...
... The following is a statement from Georges C. Ben...the American Public Health Association: , , "The ...her leading health organizations, members of Congr...prevention, the inclusion of health reform funds i...
Other Medicine News:Health News:University of Pittsburgh Medical Center to Manage New Health Center in Cyprus 2Health News:University of Pittsburgh Medical Center to Manage New Health Center in Cyprus 3Health News:University of Pittsburgh Medical Center to Manage New Health Center in Cyprus 4Health News:MS Research, Funding Speed Development of New Therapies 2Health News:Cell Therapeutics Reschedules Special Meeting 2Health News:Cell Therapeutics Reschedules Special Meeting 3Health News:U.S. Preventive Medicine(R), ParkwayHealth Sign Affiliation Agreement to Jointly Deliver Preventive Medicine Services in Asia 2Health News:U.S. Preventive Medicine(R), ParkwayHealth Sign Affiliation Agreement to Jointly Deliver Preventive Medicine Services in Asia 3Health News:Select Comfort Launches Entirely Redesigned Line Of Sleep Number Beds 2Health News:Select Comfort Launches Entirely Redesigned Line Of Sleep Number Beds 3Health News:Select Comfort Launches Entirely Redesigned Line Of Sleep Number Beds 4
(Date:12/1/2009)..., ALBUQUERQUE, N.M., Dec. 1 Exa...oratory that discovers, develops and markets propr...ent of Scott Glenn as chairman of the company,s bo..., Prior to joining Exagen, Glenn was managing part... number of successful biomedical companies includi...
(Date:12/1/2009)... , BRIDGEWATER, N.J., Dec. 1 T...Biotech Products, L.P., announced today that it is...issues affecting women and people of color living ...cluding local educational events, media outreach a...mpany is sharing learnings from the GRACE study, t...
(Date:12/1/2009)... , NEW YORK, Dec. 1 ... changing market dynamics for an industry experien...thcare reforms are likely to drive up the effecti...nces industry, according to a report released tod...: Taxing times ahead - Which path will you take? ...
Breaking Medicine Technology:Scott Glenn Joins Exagen Diagnostics as Chairman and CEO 2Tibotec Therapeutics Launches GRACE Campaign for Women and People of Color Living With HIV/AIDS 2Tibotec Therapeutics Launches GRACE Campaign for Women and People of Color Living With HIV/AIDS 3Tibotec Therapeutics Launches GRACE Campaign for Women and People of Color Living With HIV/AIDS 4Tibotec Therapeutics Launches GRACE Campaign for Women and People of Color Living With HIV/AIDS 5Tibotec Therapeutics Launches GRACE Campaign for Women and People of Color Living With HIV/AIDS 6Tibotec Therapeutics Launches GRACE Campaign for Women and People of Color Living With HIV/AIDS 7Pharmaceutical and Life Sciences Companies Face Rising Tax Rates, Says PricewaterhouseCoopers 2Pharmaceutical and Life Sciences Companies Face Rising Tax Rates, Says PricewaterhouseCoopers 3Pharmaceutical and Life Sciences Companies Face Rising Tax Rates, Says PricewaterhouseCoopers 4Pharmaceutical and Life Sciences Companies Face Rising Tax Rates, Says PricewaterhouseCoopers 5Apple Vending is a Strong Growth Segment Despite Tough Economic Times 59884 1Apple Vending is a Strong Growth Segment Despite Tough Economic Times 59884 2Apple Vending is a Strong Growth Segment Despite Tough Economic Times 59884 3McDivitt Law Firm 26apos 3Bs Treat Is No Trick Free Rides on Halloween in Colorado Springs 59881 1McDivitt Law Firm 26apos 3Bs Treat Is No Trick Free Rides on Halloween in Colorado Springs 59881 2McDivitt Law Firm 26apos 3Bs Treat Is No Trick Free Rides on Halloween in Colorado Springs 59881 3Aprima 2009 First Electronic Health Record and Practice Management System to Announce Support for Microsoft Windows 7 59878 1Aprima 2009 First Electronic Health Record and Practice Management System to Announce Support for Microsoft Windows 7 59878 2
...pril 4, 2007 -- CytImmune, a,clinical stage nanom...mercialization of multifunctional, tumor-targeted ...stract at the 43rd American,Society of Clinical On...5. The poster session will take place from 8:00 am...of CytImmune will,present the poster abstract enti...
... Journal of Cell Science Shows ONCONASE Uptake in,... April 05, 2007 /PRNewswire-FirstCall/ --,Alfacell...hers have,identified the pathway that ONCONASE (ra...he Journal of Cell Science (2007; 120: 1405-1411),...ity of Girona in,Spain and the University of Montp...
Other Medicine Technology:CytImmune To Present At ASCO Phase I Clinical Trial of CYT-6091 to,be Presented on June 3, 2007 2Researchers Identify Intracellular Pathway of Alfacell's Onconase 2Researchers Identify Intracellular Pathway of Alfacell's Onconase 3
Micro Wire Driver
SmartDriver
...stem is a full-function, electric powered system t...ange of surgical applications including Arthroscop... Orthopedic Trauma, Oral and Maxillofacial Surgery... Because it is a complete, standardized and specia...
...nsists of a pistol-grip handpiece available in Pne...nge of couplers that can be used in a variety of o...artDriver XT offers significantly increased torque...river. The Battery SmartDriver XT accepts the full...
Medicine Products: